Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

HZE Radiation Non-Targeted Effects on the Microenvironment That Mediate Mammary Carcinogenesis.

Barcellos-Hoff MH, Mao JH.

Front Oncol. 2016 Mar 11;6:57. doi: 10.3389/fonc.2016.00057. eCollection 2016. Review.

2.

Quantitative proteomic analyses of mammary organoids reveals distinct signatures after exposure to environmental chemicals.

Williams KE, Lemieux GA, Hassis ME, Olshen AB, Fisher SJ, Werb Z.

Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):E1343-51. doi: 10.1073/pnas.1600645113. Epub 2016 Feb 22.

PMID:
26903627
3.

Dequalinium blocks macrophage-induced metastasis following local radiation.

Timaner M, Bril R, Kaidar-Person O, Rachman-Tzemah C, Alishekevitz D, Kotsofruk R, Miller V, Nevelsky A, Daniel S, Raviv Z, Rotenberg SA, Shaked Y.

Oncotarget. 2015 Sep 29;6(29):27537-54. doi: 10.18632/oncotarget.4826.

4.

The effect of environmental chemicals on the tumor microenvironment.

Casey SC, Vaccari M, Al-Mulla F, Al-Temaimi R, Amedei A, Barcellos-Hoff MH, Brown DG, Chapellier M, Christopher J, Curran CS, Forte S, Hamid RA, Heneberg P, Koch DC, Krishnakumar PK, Laconi E, Maguer-Satta V, Marongiu F, Memeo L, Mondello C, Raju J, Roman J, Roy R, Ryan EP, Ryeom S, Salem HK, Scovassi AI, Singh N, Soucek L, Vermeulen L, Whitfield JR, Woodrick J, Colacci A, Bisson WH, Felsher DW.

Carcinogenesis. 2015 Jun;36 Suppl 1:S160-83. doi: 10.1093/carcin/bgv035. Review.

5.

Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgen-deprivation therapy.

Shiota M, Yokomizo A, Takeuchi A, Imada K, Kiyoshima K, Inokuchi J, Tatsugami K, Ohga S, Nakamura K, Honda H, Naito S.

Oncotarget. 2015 Jun 10;6(16):14710-9.

6.

Identification of genetic loci that control mammary tumor susceptibility through the host microenvironment.

Zhang P, Lo A, Huang Y, Huang G, Liang G, Mott J, Karpen GH, Blakely EA, Bissell MJ, Barcellos-Hoff MH, Snijders AM, Mao JH.

Sci Rep. 2015 Mar 9;5:8919. doi: 10.1038/srep08919.

7.

Distinct luminal-type mammary carcinomas arise from orthotopic Trp53-null mammary transplantation of juvenile versus adult mice.

Nguyen DH, Ouyang H, Mao JH, Hlatky L, Barcellos-Hoff MH.

Cancer Res. 2014 Dec 1;74(23):7149-58. doi: 10.1158/0008-5472.CAN-14-1440. Epub 2014 Oct 3.

8.

Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis?

Bizzarri M, Cucina A.

Biomed Res Int. 2014;2014:934038. doi: 10.1155/2014/934038. Epub 2014 Jun 12. Review.

9.

Alteration of radiation-sensitive processes associated with cancer and longevity by dietary 2-mercaptoethanol.

Click RE.

J Cancer Res Ther. 2014 Jan-Mar;10(1):127-32. doi: 10.4103/0973-1482.131450.

10.

Competing views on cancer.

Sonnenschein C, Soto AM, Rangarajan A, Kulkarni P.

J Biosci. 2014 Apr;39(2):281-302.

11.

Proton irradiation augments the suppression of tumor progression observed with advanced age.

Beheshti A, Peluso M, Lamont C, Hahnfeldt P, Hlatky L.

Radiat Res. 2014 Mar;181(3):272-83. doi: 10.1667/RR13538.1. Epub 2014 Feb 25.

12.

Radiation-enhanced lung cancer progression in a transgenic mouse model of lung cancer is predictive of outcomes in human lung and breast cancer.

Delgado O, Batten KG, Richardson JA, Xie XJ, Gazdar AF, Kaisani AA, Girard L, Behrens C, Suraokar M, Fasciani G, Wright WE, Story MD, Wistuba II, Minna JD, Shay JW.

Clin Cancer Res. 2014 Mar 15;20(6):1610-22. doi: 10.1158/1078-0432.CCR-13-2589. Epub 2014 Jan 31.

13.

Microvesicles secreted from human multiple myeloma cells promote angiogenesis.

Liu Y, Zhu XJ, Zeng C, Wu PH, Wang HX, Chen ZC, Li QB.

Acta Pharmacol Sin. 2014 Feb;35(2):230-8. doi: 10.1038/aps.2013.141. Epub 2013 Dec 30.

14.

Emerging targets in cancer management: role of the CXCL12/CXCR4 axis.

Cojoc M, Peitzsch C, Trautmann F, Polishchuk L, Telegeev GD, Dubrovska A.

Onco Targets Ther. 2013 Sep 30;6:1347-61. doi: 10.2147/OTT.S36109. Review.

15.

Redox-mediated and ionizing-radiation-induced inflammatory mediators in prostate cancer development and treatment.

Miao L, Holley AK, Zhao Y, St Clair WH, St Clair DK.

Antioxid Redox Signal. 2014 Mar 20;20(9):1481-500. doi: 10.1089/ars.2013.5637. Epub 2014 Jan 22. Review.

16.

Cell death-stimulated cell proliferation: a tissue regeneration mechanism usurped by tumors during radiotherapy.

Zimmerman MA, Huang Q, Li F, Liu X, Li CY.

Semin Radiat Oncol. 2013 Oct;23(4):288-95. doi: 10.1016/j.semradonc.2013.05.003. Review.

17.

Oncogenic transformation of mammary epithelial cells by transforming growth factor beta independent of mammary stem cell regulation.

Dunphy KA, Seo JH, Kim DJ, Roberts AL, Tao L, DiRenzo J, Balboni AL, Crisi GM, Hagen MJ, Chandrasekaran T, Gauger KJ, Schneider SS, Jerry DJ.

Cancer Cell Int. 2013 Jul 25;13:74. doi: 10.1186/1475-2867-13-74. eCollection 2013.

18.

Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk.

Braunstein S, Nakamura JL.

Front Oncol. 2013 Apr 3;3:73. doi: 10.3389/fonc.2013.00073. eCollection 2013.

19.

Tumor-immune dynamics regulated in the microenvironment inform the transient nature of immune-induced tumor dormancy.

Wilkie KP, Hahnfeldt P.

Cancer Res. 2013 Jun 15;73(12):3534-44. doi: 10.1158/0008-5472.CAN-12-4590. Epub 2013 Mar 27.

20.

MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transition.

DeCastro AJ, Dunphy KA, Hutchinson J, Balboni AL, Cherukuri P, Jerry DJ, DiRenzo J.

Cell Death Dis. 2013 Feb 28;4:e514. doi: 10.1038/cddis.2013.37.

Items per page

Supplemental Content

Write to the Help Desk